Main-blog-page-header

Sharing perspectives leads to greater understanding and fuels innovation. The ​Optum Insights ​blog is where we share our perspective and challenge preconceptions to clear a new path forward



  • New Hampshire decision may open door for medical marijuana in workers’ comp

    by
    | Mar 14, 2019
    Tag Icon
    Pain Management, Workers Comp, workers compensation, Medical Marijuana
    Whether medical marijuana will be permitted in workers’ compensation is a hot topic. A recent Supreme Court decision in New Hampshire may open the door for medical marijuana in workers’ comp. Read more on our Policy Matters blog.


  • PBM 101: A refresher on the role of pharmacy management in workers’ comp

    by
    • Katie Dwyer - Risk & Insurance
    | Mar 12, 2019
    Tag Icon
    Workers' Compensation, workers compensation, Workers Comp, PBM
    Increasingly, PBMs are relying on massive stores of data to identify broader patterns that inform individual prescription decisions. According to David Young, President and CEO of Optum Workers’ Compensation and Auto No-fault, this is a PBM’s true value proposition.


  • FDA advisory committees recommend approval of esketamine nasal spray for treatment-resistant depression

    by
    • Optum for Workers' Compensation
    | Feb 27, 2019
    Tag Icon
    FDA
    Treatment-resistant depression (TRD), is typically defined as failing trials of at least two antidepressant treatments for major depressive disorder. The FDA is expected to make its decision in early March. See potential impact for workers’ comp on our blog.


  • How to avoid unintended consequences when new policies are implemented

    by
    • Optum Workers Comp
    | Feb 26, 2019
    Tag Icon
    Government Affairs
    They say an ounce of prevention is worth a pound of cure. This axiom applies to collaborating on workers’ comp policy development with state and federal policymakers.


  • FDA approves first generic of Advair Diskus® inhaler for asthma and COPD

    by
    • Optum for Workers' Compensation
    | Feb 05, 2019
    Tag Icon
    Generics, FDA, FDA approved, Pharmacy, workers compensation, Clinical
    After almost 20 years on the market as a name-brand medication, the FDA has approved the first generic version of Advair Diskus inhaler for asthma and COPD. See availability, timing, dosing and relevance to work comp on our blog.


  • New York revises drug formulary proposal and releases updated medication list

    by
    • Optum Workers Comp
    | Jan 28, 2019
    Tag Icon
    workers compensation, Government Affairs, Drug Formulary
    The New York Workers’ Compensation Board (WCB) has released a third proposed rule version of the drug formulary and an updated drug list. This action follows the WCB’s review of submitted comments, as well as continued collaboration with stakeholders.


  • Register for 2019 Continuing Education

    by
    • Optum Workers' Comp
    | Jan 25, 2019
    Tag Icon
    Government Affairs, Webinar - Workers' Compensation, workers compensation, Settlement, Pharmacy, Pain Management, Clinical, Continuing Education
    From the state house, to the pharmacy, to claim resolution, Optum is kicking off its 2019 continuing education calendar with "What to watch for in 2019." See our full year of topics & register to gain the knowledge you need to move move forward this year!



Stay informed by receiving latest updates

Do you have a question about a blog post?